2252.HK
MEDBOT-B
HK$24.92
-1.66%
2026-06-01
About MEDBOT-B
Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, manufacturing, and sale of surgical robots in the People's Republic of China. The company offers Toumai laparoscopic surgical robot; Toumai single port laparoscopic surgical robot; DFVision 3D electronic laparoscope; SkyWalker orthopedic surgical robot; trans-bronchial surgical robot for natural orifice surgery; R-ONE vascular interventional robot for pan vascular surgery; and iSR'obot Mona Lisa robotic trans perineal prostate biopsy system. It is also involved in the distribution of surgical robot devices. The company was founded in 2014 and is headquartered in Shanghai, China. Shanghai MicroPort MedBot (Group) Co., Ltd. operates as a subsidiary of Shanghai Latent Artificial Intelligence Co., Ltd.
Key Fundamentals
Forward P/E
78.46
EPS (TTM)
HK$-0.28
ROE
-77.3%
Revenue Growth (YoY)
137.6%
Profit Margin
-45.3%
Debt/Equity
102.66
Price/Book
55.10
Beta
1.51
Market Cap
HK$26.13B
Avg Volume (10D)
5.8M
Recent Breakout Signals
No recent breakout signals detected for 2252.HK.
Recent Price Range (60 Days)
60D High
HK$35.34
60D Low
HK$22.18
Avg Volume
6.1M
Latest Close
HK$24.92
Get breakout alerts for 2252.HK
Sign up for Breakout Scanner to receive daily notifications when 2252.HK triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
MEDBOT-B (2252.HK) is listed on the Hong Kong Exchanges (HKEX). Breakout Scanner monitors 2252.HK daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. 2252.HK operates in the Healthcare sector within the Medical Devices industry. Data is provided for informational purposes only and does not constitute financial advice.